# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omni...
Omnipod 5, the world's first tubeless automated insulin delivery (AID) system integrated with Dexcom G6, is now available...
OTR Global downgrades Insulet (NASDAQ:PODD) from Positive to Mixed.
Redburn Atlantic analyst Issie Kirby initiates coverage on Insulet (NASDAQ:PODD) with a Buy rating and announces Price Targe...
Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price ...